𝔖 Bobbio Scriptorium

✦ LIBER ✦

Re: Surgical Morbidity Associated with Administration of Targeted Molecular Therapies before Cytoreductive Nephrectomy or Resection of Locally Recurrent Renal Cell Carcinoma

✍ Scribed by Robert C. Flanigan; Anthony Pulcari

Book ID: 113611269
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 112 KB
Volume: 55
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2009.01.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to: “Re: Surgical Morbidity

Corrigendum to: “Re: Surgical Morbidity Associated with Administration of Targeted Molecular Therapies before Cytoreductive Nephrectomy or Resection of Locally Recurrent Renal Cell Carcinoma” [Eur Urol 2009;55:990–1]

✍ Robert C. Flanigan; Anthony Polcari 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

POD-6.07: Surgical Morbidity Associated

POD-6.07: Surgical Morbidity Associated with Administration of Targeted Molecular Therapies Prior to Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

✍ C. Wood; V. Margulis; S. Matin; P. Tamboli; D. Swanson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Surgical morbidity associated with admin

Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma: Margulis V, Matin SF, Tannir N, Tamboli P, Swanson DA, Jonasch E, Wood CG, Department of Urology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX

✍ Michael L. Blute 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 86 KB